Immunoprecise Antibodies Ltd(IPA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

IPA Immunoprecise Antibodies Ltd

Trading 04-11 10:39:19 EDT

0.3927

-0.0083

-2.07%

High0.4499	Low0.3900	Vol972.80K
Open0.4130	D1 Closing0.4010	Amplitude14.94%
Mkt Cap17.97M	Tradable Cap16.32M	Total Shares45.77M
T/O403.50K	T/O Rate2.34%	Tradable Shares41.56M
P/B1.00	ROE-124.75%	EPS-1.13
52wk High1.40	52wk Low0.2700	P/E-0.35
Dividend0.00	Div.Yield0.00	ROA-14.88%

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"IPA","market":"US","secType":"STK","nameCN":"Immunoprecise Antibodies Ltd","latestPrice":0.3927,"timestamp":1744382346127,"preClose":0.401,"halted":0,"volume":972800,"delay":0,"floatShares":41560731,"shares":45765118,"eps":-1.125858,"marketStatus":"Trading","change":-0.0083,"latestTime":"04-11 10:39:17 EDT","open":0.413,"high":0.4499,"low":0.39,"amount":403503.859712,"amplitude":0.149377,"askPrice":0.4097,"askSize":500,"bidPrice":0.3927,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.125858,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1744401600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.401,"preHourTrading":{"tag":"盘前","latestPrice":0.4021,"preClose":0.401,"latestTime":"09:27 EDT","volume":207159,"amount":95577.84690006,"timestamp":1744378030465},"postHourTrading":{"tag":"盘后","latestPrice":0.44,"preClose":0.401,"latestTime":"19:58 EDT","volume":116250,"amount":51252.88909,"timestamp":1744329521375},"volumeRatio":13.382156,"impliedVol":0.7934,"impliedVolPercentile":0.0598},"requestUrl":"/m/hq/s/IPA/tweets","defaultTab":"tweets","newsList":[{"id":"2524143340","title":"ImmunoPrecise Antibodies Price Target Maintained With a $3.00/Share by Benchmark","url":"https://stock-news.laohu8.com/highlight/detail?id=2524143340","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524143340?lang=en_us&edition=full_marsco","pubTime":"2025-04-01 22:54","pubTimestamp":1743519240,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IPA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 01, 2025 10:54 ET (14:54 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPA"],"gpt_icon":0},{"id":"2523912557","title":"ImmunoPrecise Antibodies Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2523912557","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523912557?lang=en_us&edition=full_marsco","pubTime":"2025-03-31 18:53","pubTimestamp":1743418380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IPA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 31, 2025 06:53 ET (10:53 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPA"],"gpt_icon":0},{"id":"2523911912","title":"ImmunoPrecise Antibodies price target lowered to $5 from $7 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2523911912","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523911912?lang=en_us&edition=full_marsco","pubTime":"2025-03-31 18:10","pubTimestamp":1743415844,"startTime":"0","endTime":"0","summary":"H.C. Wainwright lowered the firm’s price target on ImmunoPrecise Antibodies (IPA) to $5 from $7 and keeps a Buy rating on the shares. The firm cite...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/immunoprecise-antibodies-price-target-lowered-to-5-from-7-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/immunoprecise-antibodies-price-target-lowered-to-5-from-7-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IPA","BK4121"],"gpt_icon":0},{"id":"2523635694","title":"ImmunoPrecise Antibodies Third Quarter 2025 Earnings: CA$0.66 loss per share (vs CA$0.11 loss in 3Q 2024)","url":"https://stock-news.laohu8.com/highlight/detail?id=2523635694","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523635694?lang=en_us&edition=full_marsco","pubTime":"2025-03-29 20:33","pubTimestamp":1743251626,"startTime":"0","endTime":"0","summary":"AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.NasdaqCM:IPA Earnings and Revenue Growth March 29th 2025. All figures shown in the chart above are for the trailing 12 month  period. Looking ahead, revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 5.9% growth forecast for the Life Sciences industry in the US.The company's shares are down 7.4% from a week ago.Before we wrap up, we've discovered 3 warning signs for ImmunoPrecise Antibodies (1 is concerning!","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/immunoprecise-antibodies-third-quarter-2025-123346678.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CA","IPA"],"gpt_icon":0},{"id":"2522577545","title":"Immunoprecise Antibodies Ltd reports results for the quarter ended January 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2522577545","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522577545?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 21:31","pubTimestamp":1743168712,"startTime":"0","endTime":"0","summary":"Immunoprecise Antibodies Ltd reports results for the quarter ended January 31 - Earnings SummaryImmunoprecise Antibodies Ltd IPA.OQ reported a quarterly adjusted loss of 1 cent per share for the quart","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nL5N3QB14S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPA"],"gpt_icon":0},{"id":"2522336579","title":"BRIEF-Immunoprecise Antibodies (IPA) Reports Financial Results And Recent Business Highlights For Third Quarter Fiscal Year 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2522336579","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522336579?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 20:37","pubTimestamp":1743165434,"startTime":"0","endTime":"0","summary":"BRIEF-Immunoprecise Antibodies (IPA) Reports Financial Results And Recent Business Highlights For Third Quarter Fiscal Year 2025March 28 (Reuters) - Immunoprecise Antibodies Ltd IPA.O:IMMUNOPRECISE AN","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nTUA7XQ6GY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPA","BK4121"],"gpt_icon":0},{"id":"2522784573","title":"ImmunoPrecise Antibodies Q3 2025 GAAP EPS C$(0.66) May Not Be Comparable To C$(0.08) Estimate, Sales C$6.15M Miss C$6.58M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2522784573","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522784573?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 20:05","pubTimestamp":1743163536,"startTime":"0","endTime":"0","summary":"ImmunoPrecise Antibodies (NASDAQ:IPA) reported quarterly losses of $(0.66) per share which missed the analyst consensus estimate of $(0.08) by 725 percent. This is a 725 percent decrease over losses of $(0.08) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44534296/immunoprecise-antibodies-q3-2025-gaap-eps-c-0-66-may-not-be-comparable-to-c-0-08-estimate-sales-c-6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPA"],"gpt_icon":0},{"id":"2522657397","title":"Immunoprecise Antibodies Q3 Revenue CAD 6.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2522657397","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522657397?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 20:01","pubTimestamp":1743163260,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nPLX74E2DC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IPA","BK4121"],"gpt_icon":0},{"id":"2522573991","title":"Immunoprecise Antibodies Ltd: Qtrly Shr Loss $0.66","url":"https://stock-news.laohu8.com/highlight/detail?id=2522573991","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522573991?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 20:01","pubTimestamp":1743163260,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nPLX74E2DC:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","IPA"],"gpt_icon":0},{"id":"2522857391","title":"Immunoprecise Antibodies (Ipa) Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2522857391","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522857391?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 20:01","pubTimestamp":1743163260,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nTUA7XQ6GY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","IPA"],"gpt_icon":0},{"id":"2522957392","title":"Press Release: ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2522957392","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522957392?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 20:01","pubTimestamp":1743163260,"startTime":"0","endTime":"0","summary":"ImmunoPrecise Antibodies  Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025. Scales AI Infrastructure Collaborations with Vultr and Leading Providers of Advanced GPU technologies to Accelerate de novo Drug Discovery.Kamil Isaev, Joseph Scheffler, and Dr. Li Hui join IPA, enhancing leadership in AI, finance, and client relations.IMMUNOPRECISE ANTIBODIES LTD.  , an AI-driven biotherapeutic research and technology company, today reported financial results for the third quarter  of its 2025 fiscal year , which ended January 31, 2025.\"While BioStrand's AI revenue currently represents a modest portion of our total topline, it stands out for its remarkably high gross margins--exceeding 90% in recent quarters, a level of profitability that is truly exceptional in our industry. This positive dynamic reveals one of the most important yet underappreciated financial drivers of our business: as AI revenues scale, so does the path to profitability at an acce","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TM","BK4121","BK4588","BK4099","BK4604","03160","IPA","BK4022","BK4555","BK4585","R","BK4232"],"gpt_icon":0},{"id":"2520437256","title":"SweetWater Brewing Company and Georgia Aquarium Celebrate Third Year of Partnership with Limited Edition Aquarium-Themed Can Art for OG IPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2520437256","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520437256?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 19:00","pubTimestamp":1742468400,"startTime":"0","endTime":"0","summary":"SweetWater Brewing x Georgia Aquarium Can   SweetWater Brewing x Georgia Aquarium Can  ATLANTA, March  20, 2025  (GLOBE NEWSWIRE) -- SweetWater Brewing Company (\"SweetWater Brewing\" or \"SweetWater\"), ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/20/3046096/0/en/SweetWater-Brewing-Company-and-Georgia-Aquarium-Celebrate-Third-Year-of-Partnership-with-Limited-Edition-Aquarium-Themed-Can-Art-for-OG-IPA.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4547","BK4557","BK4007","BK4121","BK4596","08212","TLRY","IPA"],"gpt_icon":0},{"id":"2519872726","title":"ImmunoPrecise Antibodies Price Target Maintained With a $7.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2519872726","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519872726?lang=en_us&edition=full_marsco","pubTime":"2025-03-14 19:07","pubTimestamp":1741950420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IPA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 14, 2025 07:07 ET (11:07 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPA"],"gpt_icon":0},{"id":"2519826128","title":"Human rights groups challenge Apple’s privacy fight with the UK government","url":"https://stock-news.laohu8.com/highlight/detail?id=2519826128","media":"cityam","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519826128?lang=en_us&edition=full_marsco","pubTime":"2025-03-14 16:15","pubTimestamp":1741940156,"startTime":"0","endTime":"0","summary":"People walk through the Apple retail store in Grand Central Terminal  Two UK human rights groups have challenged the government’s attempts to force tech titan Apple to weaken its security systems, saying the process lacks transparency.The UK government had attempted to force Apple to create a “back door” in its implemented security systems.Liberty and Privacy International have filed a legal complaint against the tech company with the Investigatory Powers Tribunal , the Financial Times first reported.It called for Apple’s appeal against the order to be heard publicly and claimed the demand violated users’ free speech and privacy rights.Caroline Wilson Palow, legal director of Privacy International, argued: “The UK’s use of a secret order to undermine security for people worldwide is unacceptable and disproportionate.”The iPhone maker is also fighting the order issued under the Investigatory Powers Act .The firm withdrew its secure iCloud backup device from its UK market earlier this ye","market":"fut","thumbnail":"https://www.cityam.com/wp-content/uploads/2025/01/0404-Apple-logo.jpeg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2025/01/0404-Apple-logo.jpeg?w=824&h=463&crop=1"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/human-rights-groups-challenge-apples-privacy-fight-with-the-uk-government/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["BK4579","LU1582987324.SGD","SG9999015358.SGD","LU0820561818.USD","IE00B4YYXB79.USD","IPA","LU2357305700.SGD","IE000W1ABFV2.USD","LU2471134879.HKD","LU1934455194.USD","BK4515","AAPL","LU2452424414.USD","LU2023250843.SGD","SGXZ31699556.SGD","LU1037948897.HKD","SG9999014559.SGD","SG9999002224.SGD","IE00BKDWB100.SGD","SG9999014542.SGD","LU0528227936.USD","IE0009G5SDU7.USD","LU2106854487.HKD","LU2168563687.JPY","LU0345769128.USD","MACW.SI","LU0234570918.USD","LU0048584097.USD","SG9999015978.USD","LU0345770993.USD","LU0868494708.USD","LU1791710400.SGD","IE000ITXATA3.USD","LU2286300806.USD","LU1803068979.SGD","IE0003U64NQ7.SGD","IE00B19Z9505.USD","LU1242518857.USD","IE00BZ1G4Q59.USD","LU2592432038.USD","IE00BKVL7J92.USD","LU1127390331.HKD","LU0109392836.USD","LU0203202063.USD","LU2456880835.USD","LU0823421333.USD","LU2430703095.HKD","LU2552382132.HKD","LU1244550577.SGD","IE0034235303.USD"],"gpt_icon":1},{"id":"2519041850","title":"Sector Update: Health Care Stocks Softer Thursday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2519041850","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519041850?lang=en_us&edition=full_marsco","pubTime":"2025-03-14 02:05","pubTimestamp":1741889133,"startTime":"0","endTime":"0","summary":"Health care stocks fell Thursday afternoon with the NYSE Health Care Index down 0.5% and the Health Care Select Sector SPDR Fund (XLV) shedding 0.6%.The iShares Biotechnology ETF (IBB) dropped 1.1%.In","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4581","BK4121","LFWD","BK4082","IPA","XLV","DWTX","IBB","BK4604","BK4139","BK4588"],"gpt_icon":0},{"id":"2519831237","title":"Sector Update: Health Care Stocks Flat to Lower Premarket Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2519831237","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519831237?lang=en_us&edition=full_marsco","pubTime":"2025-03-13 21:11","pubTimestamp":1741871495,"startTime":"0","endTime":"0","summary":"Health care stocks were flat to lower premarket Thursday as the iShares Biotechnology ETF  was inactive and the Health Care Select Sector SPDR Fund  was recently down 0.3%.ImmunoPrecise Antibodies  shares rallied past 14% after the company announced a strategic partnership with an unnamed biotechnology company to discover and develop antibody-drug conjugates and bispecific antibodies to treat cancer.Integer Holdings  shares were down nearly 2% amid plans to offer $750 million of convertible notes due 2030.Tarsus Pharmaceuticals  shares were almost 3% lower after the company priced an upsized underwritten public offering of 2.8 million shares at $44.50 per share for gross proceeds of about $125 million.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0128526141.USD","LU1169590202.USD","LU0566484027.USD","BK4581","XLV","BK4082","LU1815336091.USD","IPA","BK4585","TARS","BK4007","LU0029874061.USD","BK4121","LU1559883803.SGD","BK4588","LU0757428866.USD","IBB","ITGR","LU1169589451.USD"],"gpt_icon":0},{"id":"2519551836","title":"Positive Signs As Multiple Insiders Buy ImmunoPrecise Antibodies Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2519551836","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519551836?lang=en_us&edition=full_marsco","pubTime":"2025-03-13 19:54","pubTimestamp":1741866850,"startTime":"0","endTime":"0","summary":"When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase stock, like in ImmunoPrecise Antibodies Ltd.'s  instance, it's good news for shareholders.Although we don't think shareholders should simply follow insider transactions, logic dictates you should pay some attention to whether insiders are buying or selling shares.Check out our latest analysis for ImmunoPrecise Antibodies. ImmunoPrecise Antibodies Insider Transactions Over The Last Year. Insiders At ImmunoPrecise Antibodies Have Bought Stock Recently. It's certainly positive to see the recent insider purchases. And an analysis of the transactions over the last year also gives us confidence. But we don't feel the same about the fact the company is making losses. While the overall levels of insider ownership are below what we'd like to see, the history of transactions imply that ImmunoPrecise Antibodies insiders are reasonably well aligned, and optimistic","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/positive-signs-multiple-insiders-buy-115410698.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IPA","BK4121"],"gpt_icon":0},{"id":"2519833104","title":"ImmunoPrecise Antibodies Signs Partnership Deal to Develop Cancer Treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2519833104","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519833104?lang=en_us&edition=full_marsco","pubTime":"2025-03-13 19:52","pubTimestamp":1741866723,"startTime":"0","endTime":"0","summary":"ImmunoPrecise Antibodies (IPA) said Thursday it has entered into a strategic partnership with an unnamed biotechnology company to discover and develop antibody-drug conjugates and bispecific antibodie","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IPA","BK4121"],"gpt_icon":0},{"id":"2519859838","title":"ImmunoPrecise in $8M deal with biotech firm for ADCs in cancer treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2519859838","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519859838?lang=en_us&edition=full_marsco","pubTime":"2025-03-13 19:10","pubTimestamp":1741864225,"startTime":"0","endTime":"0","summary":"ImmunoPrecise Antibodies (IPA) announces a strategic partnership with a leading biotechnology company with a multi-billion-dollar market capitaliza...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/immunoprecise-in-8m-deal-with-biotech-firm-for-adcs-in-cancer-treatments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/immunoprecise-in-8m-deal-with-biotech-firm-for-adcs-in-cancer-treatments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IPA","BK4121"],"gpt_icon":0},{"id":"2518084577","title":"IPA to Reschedule Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 on March 28, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2518084577","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518084577?lang=en_us&edition=full_marsco","pubTime":"2025-03-12 10:17","pubTimestamp":1741745820,"startTime":"0","endTime":"0","summary":"The Company to host an earnings conference call via webcast. AUSTIN, Texas, March 12, 2025----ImmunoPrecise Antibodies Ltd.  , a global leader in AI-powered antibody discovery and development, today announces the rescheduling of its Third Quarter Fiscal 2025 financial results and business highlights release. Originally set for March 13, 2025, the new release date is Friday, March 28, 2025, and IPA will hold an earnings call at 10:30 am Eastern Time the same day.The Company is providing additional time to allow its auditors to complete the necessary reviews and audit requirements on valuation calculations of goodwill and intangible assets. This extension ensures that the financial data accurately reflects the Company's value and complies with all regulatory requirements.The Company will host a live conference call and webcast to discuss these results and provide a corporate update on Friday, March 28, 2025, at 10:30AM ET.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ipa-reschedule-financial-results-recent-021700600.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4121","IPA"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.immunoprecise.com","stockEarnings":[{"period":"1week","weight":0.1794},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.2412},{"period":"6month","weight":-0.318},{"period":"1year","weight":-0.7115},{"period":"ytd","weight":-0.026}],"compareEarnings":[{"period":"1week","weight":-0.0226},{"period":"1month","weight":-0.0564},{"period":"3month","weight":-0.0963},{"period":"6month","weight":-0.0949},{"period":"1year","weight":0.0203},{"period":"ytd","weight":-0.1049}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its contract research organization services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation. The company has research collaboration agreements with Pierre Fabre S.A for antibody discovery; and Elektrofi, Inc. to explore a high-concentration formulation of COVID-19 antibody cocktail, PolyTope TATX-03. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.","yearOnYearQuotes":[{"month":1,"riseRate":0.8,"avgChangeRate":0.064613},{"month":2,"riseRate":0.2,"avgChangeRate":-0.147282},{"month":3,"riseRate":0.4,"avgChangeRate":-0.124046},{"month":4,"riseRate":0.4,"avgChangeRate":-0.017884},{"month":5,"riseRate":0.5,"avgChangeRate":-0.017976},{"month":6,"riseRate":0,"avgChangeRate":-0.179973},{"month":7,"riseRate":0.5,"avgChangeRate":-0.04032},{"month":8,"riseRate":0.5,"avgChangeRate":0.022134},{"month":9,"riseRate":0,"avgChangeRate":-0.148494},{"month":10,"riseRate":0.75,"avgChangeRate":0.07679},{"month":11,"riseRate":0,"avgChangeRate":-0.153626},{"month":12,"riseRate":0.75,"avgChangeRate":0.030119}],"exchange":"NASDAQ","name":"Immunoprecise Antibodies Ltd","nameEN":"Immunoprecise Antibodies Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.3","shortVersion":"4.32.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immunoprecise Antibodies Ltd(IPA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Immunoprecise Antibodies Ltd(IPA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Immunoprecise Antibodies Ltd,IPA,Immunoprecise Antibodies Ltd股票,Immunoprecise Antibodies Ltd股票老虎,Immunoprecise Antibodies Ltd股票老虎国际,Immunoprecise Antibodies Ltd行情,Immunoprecise Antibodies Ltd股票行情,Immunoprecise Antibodies Ltd股价,Immunoprecise Antibodies Ltd股市,Immunoprecise Antibodies Ltd股票价格,Immunoprecise Antibodies Ltd股票交易,Immunoprecise Antibodies Ltd股票购买,Immunoprecise Antibodies Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immunoprecise Antibodies Ltd(IPA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Immunoprecise Antibodies Ltd(IPA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}